At the European Organ-On-Chip Society meeting we will present: “3D Human Tissues Within The MIVO-Multi In Vitro Organ Fluidic Device for Improving The Outcome Of In Vitro Drug Testing Assays” to demonstrate how the MIVO® platform combined with 3D human tissues can they represent a novel, highly reliable and easy to use in vitro [...]
About Giulia PiaggioThis author has not yet filled in any details.
So far Giulia Piaggio has created 59 blog entries.
For the third straight year, the European Innovation Council has organized the EIC Corporate Days, gathering innovative European SMEs and large corporates to take full advantage of partnering opportunities. This year, the pharmaceutical giant ROCHE was also invited to meet EIC-funded SMEs and participate in the EIC Corporate Day initiative. From 22 till 25 June 2020, [...]
What we really know about drug tests: advantages and disadvantages of 3R methods and animal tests. The principles of 3R (replacement, reduction and refinement) were developed over 50 years ago to conduct research on more human animals. Biomedical research requires continuous updating on solid experimental models and in this scenario 3R-based approaches can become [...]
Our Absorption test is the innovative solution to the EU regulation 2017/745 relating to medical devicesGiulia Piaggio2020-05-29T11:54:55+00:00
Due to the health emergency of Covid19, on Thursday 23 April 2020 the European Council approved and formalized the one-year extension of the 2017/745 Regulation on medical devices, postponing their application until 26 May 2021 (https://data.consilium.europa.eu/doc/document/ST-7180-2020-INIT/en/pdf). What research areas are involved, and what it foresees this legislation, for a specific type of device, we [...]
Join our free webinar “3D human tissues and fluid-dynamic Multi-In Vitro Organ-MIVO device for in vitro testing”, Tuesday 19th May at 2:30 pmGiulia Piaggio2020-05-12T08:57:32+00:00
Are organoids and organ-on-chip the future of scientific research? With the right technology the answer is yes! Our CSO, Silvia Scaglione, introduces in this webinar the potentiality of the React4life’s patented core technologies MIVO, the fluid-dynamic multi-chamber device that allows to recreate in lab human complex systems for improving the in vitro 3D tissue [...]
To each his own therapy. Organoids, test in vitro and MIVO devices to test specific treatments suggested by our own cellsGiulia Piaggio2020-04-24T08:11:09+00:00
The technology allows us to use the so-called organoids, three-dimensional (3D) structures formed by the cells extracted from the patient himself, for in vitro tests aimed at identifying the most effective drug. Everyone is talking about personalized medicine very often, but what exactly does it mean, and how could it be possibly implemented? The [...]
The main difference between primary cells and tumor cell lines is that the first are isolated directly from healthy human or animal tissues while others have normal diploid chromosomes and maintain much of the physiological properties of the tissue from which they are derived. During drug development, and before ever administering a new drug [...]
The beauty products with anti-pollution battling skin care are on the rise in markets. The increasing pollution levels, the deteriorating air quality, the depleting ozone layer and wider climate concerns, have all caused a huge shift in consumers’ attitude over the past few years. This is one of some reason that reflected in the [...]
In Europe there is a commission, the EURL ECVAM which is an integral part of the JRC, JOINT RESEARCH CENTER which is located in Ispra, Italy. The mandate of EURL ECVAM is reported in the EU legislation relating to the protection of animals used in laboratories for scientific purposes. The purpose of the ECVAM [...]
The team describes the use of bioreactors for ligament tissue engineering applications The aim of this study was to design, develop and validate a simple, compact bioreactor system for tissue engineering. The resulting bioreactor was designed to achieve ease-of-use and low costs for automated cell-culturing procedures onto three-dimensional scaffolds under controlled torsion/traction regimes. Highly [...]